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ABSTRACT
Physical exercise can improve cognition but whether this is related to motivation
levels is unknown. Voluntary wheel running is a rewarding activity proposed as a
model of motivation to exercise. To question the potential effects of exercise
motivation on subsequent behaviour, we used a pharmacological approach targeting
some reward mechanisms. The stress hormone corticosterone has rewarding effects
mediated by activation of low affinity glucocorticoid receptors (GR). To investigate
whether corticosterone synthesis motivates exercise via activation of GRs and
subsequently, impacts on behaviour, we treated C57BL/6J mice acutely with the
inhibitor of corticosterone synthesis metyrapone (35 mg/kg) or repeatedly with the
GR antagonist mifepristone (30 mg/kg) prior to 1-hour running wheel sessions. To
investigate whether reducing motivation to exercise impacts on behaviour, we
antagonised running-induced dopamine D2/D3 receptors activation with sulpiride (25
or 50 mg/kg) and assessed locomotor, anxiety-related and memory performance after
20 running sessions over 4 weeks. We found that corticosterone synthesis contributes
to running levels, but the maintenance of running behaviour was not mediated by
activation of GRs. Intermittent exercise was not associated with changes in
behavioural or cognitive performance. The persistent reduction in exercise levels
triggered by sulpiride also had limited impact on behavioural performance, although
the level of performance for some behaviours was related to the level of exercise.
Altogether, these findings indicate that corticosterone and dopamine D2/D3 receptor
activation contribute to the motivation for wheel running, but suggest that motivation
for exercise is not a sufficient factor to alter behaviour in healthy mice.
Keywords: Corticosterone; voluntary wheel running; dopamine D2/D3 receptors;
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1. Introduction
The benefits of an active lifestyle for physical and mental health are widely
accepted. In both animals and humans, physical exercise improves cognitive function
across the lifespan and slows down the progression of cognitive disorders such as
Alzheimer’s disease [1], but the underlying mechanisms are not fully understood.
Encouraging people to exercise is, therefore, a promising strategy to promote health
but the level of participation is related to motivation factors such as
interest/enjoyment and competence which were also found to be related to positive
mental health outcomes [2]. It is however unknown whether motivational aspects of
exercise, rather than the exercise level per se, contribute to the cognitive and
behavioural effects.
Voluntary wheel running has been proposed as a preclinical model of exercise
motivation rather than of general locomotor activity based on a large body of
evidence supporting the hypothesis that rodents engage in wheel running because it
has positive salience for them (for review see [3, 4]). Wheel running was indeed
found to be reinforcing and rewarding and to activate brain rewards pathways. For
instance, rats lever-press for an opportunity to run [5], develop conditioned place
preference to the context associated with running [3, 5] and show a rebound response
to forced abstinence [3]. Furthermore, the effects of voluntary wheel running on the
brain mimic those of other natural rewards and drugs of abuse [6, 7]. Thus, the level
of exercise during voluntary wheel running is an indicator of motivation to exercise.
The effects of voluntary exercise on the brain and behaviour also differ from those of
forced exercise even when the form and level of exercise are controlled. Forced
exercise is routinely induced using a treadmill. The direct comparisons of treadmill
and voluntary wheel running showed that both procedures improved spatial memory,
but forced exercise also recruited fear-related neural pathways and increased aversive
memory [8]. The fact that treadmill running may be seen as a different form of
exercise than wheel running could contribute to the differential effects. However, by
comparing forced and voluntary wheel running, it was shown that both procedures
increased behavioural and neurochemical indices of reward, which appeared elicited
by distinct mechanisms possibly differentiating the motivation to exercise from its
rewarding effects [9]. Furthermore, similar levels of forced and voluntary wheel
running were found associated with an increase in hippocampal neurogenesis that was
greater in the forced exercise group who also showed increased anxiogenic-like
behaviour [10]. Thus, altogether these data suggest that the motivation to exercise can
exert effects on brain and behaviour that are independent of exercise levels.
The work reported here examined some mechanisms underlying the motivation
for exercise using voluntary wheel running as a model and questioned the relationship
between motivational aspects of exercise and its behavioural effects. Forced exercise
has a stressful component that may contribute to its effects on the brain [11].
Although less stressful than forced exercise [11], voluntary wheel running also
activates the hypothalamic pituitary adrenocortical (HPA) axis and elevates plasma
levels of the stress hormone corticosterone [12, 13]. Interestingly, corticosterone,
when induced or administered at sufficient levels, has direct reinforcing and
rewarding properties and enhances reinforcing and rewarding effects of abused drugs
via activation of the low affinity glucocorticoid receptor (GR) [14-18]. This raises the
question of whether corticosterone levels induced by voluntary exercise contribute to
the motivation for exercise or are induced as a consequence of exercise. The first goal
of this study was therefore to test the hypothesis that corticosterone mediates the
motivation to exercise. This was addressed by treating C57BL/6J mice acutely with
metyrapone, an inhibitor of corticosterone synthesis, prior to being allowed access to
a 1-hour running wheel sessions. Additionally, corticosterone release was found to
contribute to the improvement in memory induced by voluntary exercise [19]. The
second goal of this study was therefore to test the hypothesis that corticosterone
provokes the motivation to exercise via activation of GR receptors and, as such,
impacts on behaviour. This was addressed by treating C57BL/6J mice repeatedly with
the GR antagonist mifepristone prior to being allowed access to 1-hour running wheel
sessions. An intermittent exercise regimen was chosen as the findings can be more
translated to human who exercise intermittently than unlimited access to running
wheel. Behavioural performance was assessed in locomotor, anxiety-related and
memory tests.
The final goal of this study was to investigate whether reducing the motivation
for wheel running, impacts on behaviour. Motivation for exercise has been linked to
dopaminergic reward pathways. The rewarding effects of voluntary wheel running
have been found to be associated with neuroplastic changes in the mesolimbic
pathway, that include downregulation of dopaminergic D2 receptor mRNA expression
in the nucleus accumbens core of rats [20]. Preference for voluntary exercise over
sucrose was also found reduced after treatment with the D2 antagonist haloperidol
[21]. Furthermore, the D2 antagonist raclopride reduced voluntary wheel running in
mice [22] suggesting that sustained stimulation of D2 receptors contributes to the
motivation for exercise. In addition, the motivation for wheel running was found
reduced by inactivation of the nucleus accumbens [3], a brain region where D3
receptors, which are less abundant than D2 receptors, are preferentially expressed
[23]. Thus, to reduce motivation for wheel running, we used a pharmacological
approach targeting exercise-induced activation of dopamine D2/D3 receptors with the
antagonist sulpiride [24]. Although dopamine receptors are involved both in
locomotor and motivated behaviours, sulpiride was found to be more effective on
dopamine receptors located in the mesolimbic reward pathway than in the
nigrostriatal dopamine pathways [25] and devoid of effects on spontaneous motor
activity [26]. It is, therefore, a suitable drug to block motivation for exercise.
To investigate whether motivation levels are related to the behavioural effects of
exercise, we tested the association between exercise levels and Our main findings
were that corticosterone synthesis and activation of D2/D3 receptors during voluntary
wheel running contribute to exercise levels but had a limited impact on subsequent
behavioural performance, suggesting that motivation for exercise is not a sufficient
factor to alter behaviour in healthy mice.
2. Materials and Methods
2.1. Animals
6-8-week-old male C57BL/6J mice were obtained from Charles River UK,
individually caged and left to acclimatize for 1 week. Standard environmental
conditions and 12:12 light/dark cycle (lights on at 7:00 am) were applied in the animal
holding room throughout all experiments. Mice had ad libitum access to food and
water and their body weight was recorded weekly. All procedures undertaken in these
studies were in accordance with the UK Animal Scientific Procedures Act 1986 under
project licence 40/3283. Data are reported according to the ARRIVE guidelines for in
vivo experiments [27]
2.2. Drug treatment
Metyrapone (corticosterone synthesis inhibitor), mifepristone (RU38486, GR
antagonist) and (±)-sulpiride (D2/D3 receptor antagonist) were purchased from
Sigma-Aldrich UK. Metyrapone (35 mg/kg, i.p.) was dissolved in saline. Mifepristone
(30 mg/kg, i.p.) was suspended in vehicle A, 1% Tween 80 in saline, and sonicated
for 30 seconds on ice. (±)-sulpiride (25 or 50 mg/kg, i.p.) was freshly dissolved in
vehicle B (1% acetic acid/saline) and the solution was adjusted to pH 7 with 1M
NaOH.
2.3. Running wheels
Each wheel (11.5 cm in diameter) was tightly fixed to the internal side of the
cage lid. A cycle computer was attached to the side of the cage lid and its sensor
directed at a distance of < 1 cm towards a magnet piece mounted on the wheel to
count the number of the revolutions. Cycle computers were calibrated to
automatically calculate the running distances over exercise sessions.
2.4. Spontaneous alternation in a T-maze.
The apparatus consisted of three arms of equal dimensions (41.5 cm long, 6
cm wide in grey Plexiglas surrounded by 15 cm high walls in transparent Plexiglas) as
described previously [28]. After 1-minute of habituation, mice underwent 9
consecutive trials. Each mouse was placed in the starting box (7.5 cm long) at the
beginning of the central path for 5 seconds, and once the animal entered an arm, the
doors to both arms were closed for 15 seconds. The mouse was then allowed to return
to the starting box. The test was repeated twice and the data averaged. The percentage
of correct alternations was calculated and the criterion for successful spatial working
memory performance was an alternation rate significantly above chance level (50%).
2.5. Novel object recognition and location tests.
A Perspex arena (30 × 35 × 25 cm) with transparent sides and a grey floor was
used. The behaviour was recorded by a camera positioned directly above the arena
and subsequently analysed using Ethovision Software (Noldus, Wageningen,
Netherlands). Two sets of objects were used, triangular and circular wooden blocks or
octogonal and rectangular wooden red and white blocks, counterbalanced between
mice to avoid preference bias.
Mice were first individually habituated to the empty open-field arena for 30
minutes, during which their distance travelled was automatically recorded and the
percentage of activity occurring in the centre of the arena (defined as a 21 × 8 cm
area) was also calculated to ensure that any differences in object exploration levels
between treatment groups were due to differences in memory and not activity and/or
anxiety levels.
Twenty-four hours later, each mouse was subjected to the two trials of the
object recognition test. Mice were first allowed to explore a single object for 10
minutes and 4 hours later, they could freely explore two objects, the familiar object
from the acquisition trial and a novel object (different shape) for a further 10 minutes,
as described previously [29].
Twenty-four hours later, mice were subjected to the two 10-minute trials of
the object location test, separated by 1 hour. Each mouse was first left to explore two
identical objects. The location of one object was changed during a second trial to
another corner of the arena, so that the two objects were diametrically opposed.
Object exploration, defined as the animal’s nose pointing towards the object at
a distance ≤ 0.5 cm, was assessed by eye, scored twice by an observer blind to the 
experimental groupings and averaged for each animal. If the two values differed by
more than 10%, a third scoring was performed and the two closest values were used
for statistical analyses.
The apparatus and objects were cleaned with 20% ethanol between tests to
remove olfactory cues.
2.6. Plasma corticosterone levels
Total corticosterone levels were determined using enzyme-linked
immunoassays (ADI-900-097, Enzo Life, USA) according to the manufacturer’s
instructions. The sensitivity of the assay was 27 pg/ml: the intra-assay and inter-assay
coefficients of variation were 7.7% and 9.7%, respectively. All samples were run in
duplicate. The plate was read at 405 nm and correction made at 580 nm using
SoftMax® Pro V 4.0 (Life Sciences Edition).
2.7. Statistical analysis
Data are presented as mean ± SEM and were analysed using InVivoStat [30]
as described below, with the exception of one-sample t-tests which were performed
using SPSS (SAS Institute, Inc. V16.0) to compare the percentage of correct
alternation, recognition and location indexes to chance level (50%). Details of the
statistical tests used for each experiment are described below. Correlations between
exercise levels and corticosterone or behavioural variables were also calculated using
the Pearson correlation coefficient. Our statistically significant correlation coefficients
were generally not very high as the data is generally restricted in range but can be
considered stables since our sample size exceeded 20. An effect was considered
significant when p values were ≤ 0.05 and post-hoc planned comparisons were used
where appropriate.
2.8. Study design
The first experiment investigated the development of voluntary wheel running
during repeated 1-hour sessions and whether it was associated with behavioural and
cognitive effects and corticosterone synthesis (Fig. 1A). Mice that fail to engage in
running wheel behaviour (n = 3) were excluded from the study, as it is known that
some mice do not develop consistent running behaviour [4]. Mice were first assessed
for spatial working memory performance in the spontaneous alternation test (Day 0)
and then assigned to either the running or sedentary groups (n = 10). They then
underwent a series of daily 1-hour running sessions or exposure to a static wheel (5
days/week) for 5 weeks. After the completion of the exercise regimen, mice’s
memory was evaluated in the spontaneous alternation (Day 38), open-field (Day 39),
novel object recognition and location tests (Days 40 and 41, respectively). On Day 45,
the mice were subjected to an additional running session immediately before being
sacrificed for collection of trunk blood. One-way ANOVA with repeated measures
over weeks was used to analyse the development and maintenance of running
behaviour. Two-way ANOVAs with group as the between subject factor and repeated
measures over time or trials were performed on the spontaneous alternation rate, total
exploration times during the object memory tests and body weight data. Unpaired t-
tests were used to compare sedentary and running mice for anxiety-related behaviour
in the open field, recognition and location indexes in the object tests, as well as
running distances and plasma corticosterone levels during the final running session.
Because intermittent wheel running had little effect on behaviour but induced
corticosterone synthesis, we then assessed whether corticosterone plays a role in
running performance (Fig. 2A). The first experiment indicated that running behaviour
developed gradually and that some mice failed to exhibit it. Therefore, training was
induced to ensure a sufficient level of exercise on the challenge day to accurately
assess the impact of metyrapone. 32 mice were trained for wheel-running by being
offered up to ten 1-hour running sessions. Training ended when mice were motivated
to run over 2-3 consecutive sessions reaching an average performance of about 0.3
km/hour during the last 2 training sessions. Data from the first experiment indicated
that this criterion was associated with sustained performance. Running mice were then
subjected to a final running session the next day, 30 minutes after being administered
intraperitoneally (i.p.) with saline (Running-Saline group, n = 9) or with the inhibitor
of corticosterone synthesis metyrapone (35mg/kg as in [31], Running-Metyrapone
group, n = 11). Two mice were excluded as they did not access the wheel following
the injection. The saline-treated sedentary group (Sedentary-Saline, n = 11) included
mice which failed to reach the criteria of 0.3 km/hour for 2 successive days which was
offered a static wheel during the final session for the determination of non-exercising
plasma corticosterone levels. Immediately afterwards, mice were sacrificed by
cervical dislocation and trunk blood collected for determination of plasma
corticosterone levels. The impact of metyrapone on voluntary wheel running was
assessed by comparing the average performance of running mice over the last 2
training days to that of the final session using a one-way ANOVA with treatment as
the between subject factor and repeated measures over running sessions. One-way
ANOVA, with group as the between subject factor, was used to analyse plasma
corticosterone levels at the end of the final session.
Corticosterone synthesis contributed to voluntary wheel running performance;
therefore, in the third experiment (Fig. 3C), we investigated whether the effect of
corticosterone on exercise levels was mediated by the GR receptors using the GR
antagonist mifepristone. We also investigated whether reducing motivation to run
would impact on behaviour by antagonising exercise-induced dopamine D2/D3
receptors activation with sulpiride. After acclimatization, all mice were subjected to a
2-week training phase as described above (1-hour/day, 5 days/week) to ensure that
potential drugs’ effects were not due to a lack of motivation to run. Baseline spatial
alternations performance was evaluated on Day 11. Mice were then assigned to the
sedentary (exposed to static wheels) and running groups, and further subdivided into 4
subgroups (n = 8-9) administered i.p. with vehicle (A, n = 4-5 and B, n = 4), the GR
antagonist mifepristone in vehicle A (30 mg/kg), or the D2/D3 antagonist sulpiride at
doses of 25 or 50 mg/kg (sulpiride 25 and sulpiride 50) in vehicle B. These doses
were found to be effective for 1-hour-long interventions [15, 32-34]. Sulpiride and
mifepristone were administered 30 minutes and 2 hours before each running session,
respectively. Mice were then assessed in the spontaneous alternation (Day 42), open-
field (Day 43), novel object recognition and object location tests (Days 44 and 45
respectively). On Day 49, mice were killed immediately after their final running
session by cervical dislocation. Trunk blood was collected and plasma was kept at -
80C for the determination of plasma corticosterone levels. The effect of drug
treatment on running distances was analysed using two-way ANOVAs with exercise
(running vs sedentary) and treatment (vehicle, mifepristone, sulpiride 25 and sulpiride
50) as between subject factors and repeated measure over time. Two-way ANOVAs
were used to analyse corticosterone levels, distance moved and anxiety-related
behaviour in the open field, recognition and location indexes, with exercise and
treatment as between subject factors. Three-way ANOVAs with repeated measures
were used to analyse the percentage of correct alternations, body weight, and total
exploration times during the object tests. Exercise and treatment were the between
subject factors, and alternation testing times (before and after treatment), body weight
recording times (weekly for 8 weeks) or trials (training and testing) were the within
subjects factors. Post-hoc planned comparisons were performed when appropriate,
and p < 0.05 was considered statistically significant.
2.9. Additional control groups
To control for the impact of environmental enrichment (wheel exploration) on
behavioural measures, a vehicle-treated, no-wheel group was assessed alongside (n=
8). Because we have previously found that repeated injections affect memory
performance in C57bl/6 mice [35], and to assess whether it also altered running
levels, a separate non-injected group was also included (n=8). The effects of injection
or static wheel exposure were assessed by comparing performance with vehicle-
treated mice using one way ANOVAs with repeated measure ANOVA for running
distances and unpaired t-tests for all other variables. The data are presented as
supplementary information.
3. Results
Main statistical effects for each experimental variable are reported in Table 1.
PLEASE INSERT TABLE 1 ABOUT HERE
3.1. Exercise-induced rise in corticosterone levels was not associated with
behavioural or cognitive effects.
Running behaviour developed gradually over the 5 weeks [F(4,36) = 52.59, p
< 0.0001]. During the first 3 weeks, distance travelled increased significantly from
0.143 to 0.73km (p < 0.05 for week 2 compared to both week 1 and week 3) but it
plateaued around 0.8 km/hour thereafter (Fig. 1B). On the final session, corticosterone
levels of running mice were significantly higher than those of sedentary mice offered
a static wheel [t(18) = 6.03, p < 0.0001, Fig. 1C]. Sedentary and running mice did not
differ significantly in relation to body weight gain, locomotor, anxiety-related and
memory performance (Suppl. Table 1).
PLEASE INSERT FIGURE 1 ABOUT HERE
3.2. Corticosterone synthesis contributes to voluntary wheel running
To clarify the role of corticosterone synthesis in voluntary wheel running,
mice were acutely pre-treated with metyrapone. During the last two training sessions,
mice ran an average of 0.5km per hour (Fig. 2A). Running distances were attenuated
by about 33% after metyrapone pre-treatment on the challenge day [Treatment X
running sessions: F(1,18) = 12.01, p = 0.003; post-hoc tests: p < 0.05 compared to
both training levels and Running-Saline on the final session, Fig. 2B]. The exercise-
induced rise in plasma corticosterone levels (p < 0.05 compared to Sedentary-Saline)
was also prevented by metyrapone (p < 0.05 compared to Running-Saline, Fig. 2C;
exercise X treatment : F(2,28) = 4.86, p = 0.01) and running distances of exercising
mice were positively associated with their plasma levels of corticosterone [n = 20, r =
0.39, p = 0.04, Fig. 1D]. Thus, motivation to run is, in part, supported by
corticosterone synthesis.
PLEASE INSERT FIGURE 2 ABOUT HERE
3.3. Antagonism of running-induced GR activation transiently attenuated voluntary
wheel running performance
All experimental groups achieved a similar level of exercise at the end of the
2-week training phase, running about 0.7 km/per hour (Fig. 3B). Running distances
were not affected by daily injections (Suppl. Table 2) and remained stable in the
vehicle-treated mice throughout the 4 weeks of the treatment phase (Fig. 3B).
Mifepristone transiently and moderately attenuated running behaviour, decreasing it
during the first week of treatment (p < 0.05 compared to training, Fig. 3B),
particularly on the first and third day, (p < 0.05 compared to training, Suppl. Fig. 1A)
with full recovery to training levels from week 2 (p < 0.05 for week 2, 3 and 4
compared to week 1, Fig. 3B). In contrast, sulpiride persistently decreased running
activity throughout the study in a dose-dependent manner. Pre-treatment with the 25
mg/kg dose decreased running distances by about 25% (p < 0.05 compared to training
for most sessions, Suppl. Fig. 1A and Fig. 3B) while the 50 mg/kg dose reduced
performance by 70% (p < 0.0001 compared to training for all the sessions over the 4
weeks Suppl. Fig. 1A and Fig. 3B). On the final running session, 7 days later, mice
pre-treated with 50 mg/kg of sulpiride ran significantly less than the other 3 treatment
groups (p < 0.05 in all cases, Fig. 3C). Exercise increased corticosterone levels in
vehicle- (p < 0.0001) and mifepristone-treated mice (p = 0.05), but not in sulpiride-
treated mice who had significantly lower hormone levels at the end of the running
session than those of vehicle-treated running mice (p < 0.05 in both cases, Fig. 3D).
Corticosterone levels, which were not affected by the stress of injection or
environmental enrichment (Suppl. Table 2) were positively associated with running
distances [n = 33, r = 0.42, p = 0.003, Fig. 3E].
PLEASE INSERT FIGURE 3 ABOUT HERE
3.4. Intermittent wheel-running does not impact behavioural performance
In vehicle-treated mice, no effect of exercise was found on spatial alternation
rate (Fig. 4A and Suppl. Table 3), distance moved (Fig. 5A) and anxiety-related
behaviour (Fig. 5A and Suppl. Table 3) in the open field, object exploration times in
the object recognition (Fig. 5D) and location (Fig. 5F) tests, or object and spatial
discrimination (Figs. 4B and 4C). This lack of behavioural effects is consistent with
the results of the first experiment (Suppl. Table 1) and unlikely to be confounded by
environmental enrichment or the stress of injection which had limited behavioural
impact (Suppl. Table 2). Indeed, access to a static wheel significantly increased
exploration times in both trials of the object recognition tests [F(1,14) = 20.43, p <
0.001], without affecting object recognition memory, whereas spatial discrimination
of the two additional control groups, not offered a static wheel or not subjected to the
repeated injections, was slightly improved as their location index were significantly
above chance level (Suppl. Table 2).
3.5. Mifepristone lowered memory performance regardless of exercise
The improvement in spontaneous alternation performance seen with repeated
testing was not observed in mifepristone-treated mice (Fig. 4A and Suppl. Table 3)
which, regardless of exercise, also showed reduced object recognition (p = 0.03
compared to vehicle-treated mice; Fig. 4B) while still discriminating the novel object
above chance levels (p < 0.05 compared to 50% in both cases, Fig. 4B). Open-field
behaviour (Fig. 5A and Suppl. Table 3), object exploration times (Fig. 5B and 5C)
and spatial discrimination (Fig. 4C) were not altered by antagonism of GRs regardless
of exercise.
3.6. Sulpiride had complex dose- and exercise-dependent behavioural effects
In the spontaneous alternation test, sulpiride enhanced performance of running
mice at a dose of 25 mg/kg (p = 0.008 compared to 0) and of sedentary mice at a dose
of 50 mg/kg (p = 0.02 compared to 0) by about 20% (Fig. 4B). The 25 mg/kg dose
reduced ambulatory activity in the open-field regardless of exercise (p = 0.008
compared to vehicle-treated mice; Fig. 5A), but the 50 mg/kg dose had no significant
locomotor effect (Fig. 5A). Regardless of the dose, sulpiride enhanced object
exploration in the acquisition of the object recognition test, particularly in exercising
mice (25 mg/kg: p = 0.002, 50 mg/kg: p < 0.0001 compared to vehicle-treated running
mice; Fig. 5D). The increased object investigation was also seen in the retention trial
for sulpiride 50 regardless of exercise (acquisition: p = 0.005, retention: p = 0.003
compared to vehicle-treated; Suppl. Table 3) and was associated with reduced object
recognition (p = 0.03 compared to vehicle-treated mice; Fig. 4B). In contrast, the
performance of sedentary mice treated with 25 mg/kg of sulpiride was not altered,
although antagonism of exercise-induced D2/D3 activation impaired object
recognition performance (p = 0.01 compared to vehicle-treated running mice and p =
0.005 compared to sulpiride 25-treated sedentary mice; Fig. 4B). All groups, however,
discriminated the novel object above chance levels. Similarly, in the object location
tests, regardless of the dose, sulpiride enhanced object exploration in the acquisition
trial, particularly in exercising mice (25 mg/kg: p = 0.009, 50 mg/kg: p = 0.003
compared to sulpiride-treated running mice; Fig. 5B) without significantly altering the
discrimination of spatial location (Fig. 5C). In summary, the most significant effect of
sulpiride was to increase inquisitive behaviour, particularly in running mice, but it
was without major effects on memory performance.
PLEASE INSERT FIGURE 4 and FIGURE 5 ABOUT HERE
3.7. Behavioural performance is relatively independent of the level of exercise
Correlations between the cumulative distance run over the 4 weeks of
treatment and each behavioural variable indicate weak positive associations between
the level of exercise and spatial discrimination in the object location test [n = 35, r =
0.31, p = 0.04, Fig. 4D], the number of faecal pellets in the open-field [n = 35, r =
0.29, p = 0.04, Fig. 5C] and object exploration times during the acquisition trial of the
object recognition test [n = 35, r = 0.55, p = 0.0006, Fig. 5D]. This would suggest that
the mice more motivated to run are better at spatial discrimination and more curious
whilst also being more emotional.
4. Discussion
This series of experiments questioned the relationship between motivational
aspects of exercise and its behavioural effects. We first tested the hypothesis that
corticosterone contributes to motivation for exercise and as such impacts on
behaviour and investigated whether reducing motivation for voluntary wheel running
would alter behavioural performance in in locomotor, anxiety-related and memory
tests. Our main finding is that corticosterone synthesis contributes to running
performance in mice offered intermittent access to 1-hour running wheel sessions, but
the maintenance of running behaviour does not appear to be mediated by activation of
GRs. The exercise-induced corticosterone secretion persisted after 25 sessions, but
was not associated with changes in behavioural and cognitive performance suggesting
that motivation to exercise is not sufficient to alter behaviour. Consistent with this
hypothesis, the persistent reduction in running wheel activity caused by antagonism of
dopaminergic D2/D3 receptors also had limited impact on behavioural performance.
Thus, both corticosterone synthesis and activation of dopamine D2/D3 receptors
contributed to the motivation for exercise but the level of engagement in wheel
running had limited impact on behavioural performance.
4.1. Intermittent voluntary wheel running does not alter behavioural and
cognitive performance
Unlimited access to voluntary wheel running generally improves memory in
C57BL/6J mice [36, 37]. The lack of behavioural and cognitive effects of intermittent
wheel running in our study raises the question of whether there are optimal levels of
exercise for behavioural changes to occur. Indeed, a study in rats found that
behavioural effects of exercise were dependent on the task and exercise level with low
intensity runners showing improved object recognition memory and high intensity
runners being impaired, however, increased anxiogenic-like reactions were observed
regardless of the exercise level [38]. In contrast, our correlation data would suggest
that the mice keener on running are better at spatial discrimination and are less
curious whilst also being more emotional. The source of this discrepancy could be the
specie or related to exercise levels as we applied an intermittent exercise regimen
while the study reported provided unlimited access to wheel running [38]. The timing
of exercise can also be a significant factor. Although mice are nocturnal and, when
given unlimited access to a running wheel, they preferentially exercise during the
night, running distances were only found to be affected during the light phase when
access to exercise was given for more than 1 hour [39]. However, C57BL/6J mice had
to run for at least 3 hours at night to demonstrate a significant increase in
hippocampal neurogenesis [39], a mechanism thought to mediate the cognition-
enhancing effects of exercise [37, 40]. It is therefore possible that the behavioural
impact of intermittent exercise would be greater if it was applied during the dark
phase of the cycle.
Other methodological factors could contribute to the lack of behavioural
effects of exercise and were controlled for here. First, we found previously that the
repeated stress of injection impairs memory in C57BL/6J mice [35], but it had no
impact on running activity and behavioural effects of exercise in the present study.
Novelty and environmental enrichment can also contribute to the positive effects of
exercise [41] but this was not the case here. We showed previously that repeated
exposure to a novel environment, which also induces physical exercise, improved
memory in a mouse model of Alzheimer’s disease but not in wild-type C57BL/6J
mice [35, 42, 43] while exposure to a static wheel was sufficient to improve some
cognitive measures in another Alzheimer’s mouse model [44]. Altogether, this
suggests that the enrichment aspect of exercise may only beneficial to cognitive
performance in animals with pre-existing memory impairments.
4.2. Corticosterone synthesis motivates voluntary wheel running
Voluntary wheel running-induced corticosterone secretion was positively
associated with running distances during the final exercise session as well as total
distance run throughout the experiment (Suppl. Fig. 1B), ruling out habituation of the
HPA axis to the repeated exercise. This is in agreement with previous work in mice
selectively bred for high engagement in voluntary wheel running, showing that the
acute corticosterone response to exercise is unaffected by repeated voluntary exercise
[45]. The positive correlation between running distances and corticosterone secretion
raised the question of whether corticosterone levels are a cause or a consequence of
running behaviour. While the elevation in corticosterone levels resulting from forced
exercise [46] would indicate that it results from the stress of running, we found that
metyrapone significantly decreased the running distances of trained mice after a
single session. Both inhibition of corticosterone synthesis with metyrapone and
adrenalectomy were previously found to moderately reduce running distances of rats
offered unlimited access to running wheels [19]. This indicates that corticosterone
regulates the motivation to run but is not necessary for the acquisition and
maintenance of running behaviour. One possibility is that it exerts reinforcing effects
once a certain level of exercise and/or corticosterone is achieved. GRs, which are
activated by stress levels of the hormone, are important for rewarding and reinforcing
effects of abused drugs in animals [14, 15] and are thought to mediate the rewarding
effects of corticosterone [47]. The moderate and short-lasting effects of mifepristone
on voluntary running activity suggest that motivating effects may possibly be initiated
via a GR-dependent mechanism, but not their persistence. This is in agreement with
the observation that GR levels were found to be unaltered by 4 weeks of voluntary
wheel running, despite a downregulation of the high affinity mineralocorticoid
receptors [13] which may thus contribute more to motivation to exercise than GRs.
Corticosterone plays a critical role in cognitive performance [48], can prevent
memory impairments [17] and corticosterone secretion was found to mediate the
improvement in memory induced by voluntary exercise [19]. We, however, found that
mifepristone had only weak effects on memory performance independent of exercise,
also suggesting that GRs do not mediate the cognitive effects of exercise.
4.3. Reducing motivation for exercise has limited behavioural impact
Dopamine has been suggested to influence learning and memory especially
when a motivated behaviour is involved [49]. The repeated treatment with sulpiride
had no impact on cognitive performance in the absence of exercise, and only reduced
spontaneous alternation performance after exercise at the lowest dose. However,
antagonism of exercise–induced D2/D3 receptors activation significantly increased
object investigation in the object recognition and location tasks, suggesting a
persistent increase in inquisitive behaviour. Chronic sulpiride treatment was found to
up-regulate dopamine D3 receptor levels without affecting D1 and D2 levels [50].
This may be interpreted as a compensatory mechanism responding to the blockade of
D3 receptors, which is potentially cognition-enhancing [51]. However, long term
blockade of D2 receptors can lead to increased dopamine release and the activation of
other dopamine receptors [52]. Thee higher availability of D3 receptors would thus be
consistent with the observation that stimulation of D3 receptors impairs performance
in the novel object test [53]. Furthermore, stimulation of D4 receptors was found to
stimulate object exploration [54] as was observed in sulpiride-treated mice.
Conclusions
This study has demonstrated that enhanced corticosterone synthesis mediates
voluntary wheel running, albeit to a lesser extent than dopamine D2/D3 receptor
activation, and as such contribute to the motivation for exercise. GRs activation,
however, was not required for mice to sustain running activity. The exercise regimen
used here failed to improve memory, although we found that performance of some
behaviours was related to exercise level. Thus, under certain circumstances,
motivation for exercise may contribute to its behavioural effects. Further studies are,
however, needed to address whether this is only true in the case of pre-existing
cognitive impairments.
Table and figure legends.
Figure 1. Corticosterone response to exercise induced by voluntary wheel
running A) Timeline of the experiment. Mice were offered access to a running or
static wheel for 1 hour 5 times a week for 5 weeks after baseline assessment of
spontaneous alternation performance. They were assessed for locomotor activity,
anxiety-related behavior, spatial and recognition memory after the exercise regimen
and offered a final running session the following week for determination of exercise-
induced corticosterone levels. B) Mean + SE weekly distance ran (km). Running
activity developed gradually over the first 3 weeks and then plateaued at about 0.8
km/hour. ***p < 0.0001 and **p < 0.01 compared to previous week. C) Mean + SE
plasma corticosterone levels (ng/ml) increased with exercise. ***p < 0.0001
compared to exposure to a static wheel.
Figure 2. Corticosterone synthesis mediates voluntary wheel running. A)
Timeline of the experiment. Trained mice were offered access to a running or static
wheel for 1 hour, 30 minutes after administration of the corticosterone synthesis
inhibitor metyrapone (35 mg/kg, i.p.) or its vehicle (saline). They were culled
immediately after for determination of exercise-induced corticosterone in plasma. B)
Mean + SE distance (km) ran during the last 2 training sessions and on the drug
challenge day. Inhibition of corticosterone synthesis significantly decreases running
activity. **p < 0.01 compared to training levels and *p < 0.05 compared to saline-
treated mice. C) Mean + SE plasma corticosterone levels (ng/ml) after exercise.
Metyrapone prevented exercise-induced corticosterone levels. **p < 0.01 and *p <
0.05 compared to saline-treated running mice. D) Plasma corticosterone levels during
the final running session were positively associated with exercise levels.
Figure 3. Activation of dopamine D2/D3 receptors mediates voluntary wheel
running. A) Timeline of the experiment. In trained mice, after baseline assessment of
spontaneous alternation performance, the glucocorticoid receptor (GRs) antagonist
mifepristone (30 mg/kg i.p.) and the D2/D3 antagonist (25 or 50 mg/kg i.p.) were
administered prior to each running session to determine the extent to which their
activation during exercise contributes to running activity. Mice were assessed for
locomotor activity, anxiety-related behavior, spatial and recognition on week 7 and
offered a final running session the following week to determine whether blockade of
GR and D2/D3 receptors also impact on exercise-induced corticosterone levels. B)
Mean + SE weekly distance ran (km). Antagonism of exercised-induced GR
activation attenuates running levels during the first week of treatment while
antagonism of D2/D3 receptor activation dose-dependently reduces running distances.
***p < 0.0001, **p < 0.01 and *p < 0.05 compared to pre-treatment levels. C) Mean
+ SE distance (km) ran during the final exercise session. **p < 0.01 and *p < 0.05
compared to saline-treated running mice. D) Mean + SE plasma corticosterone levels
(ng/ml) after exercise. Antagonism of D2/D3 receptors prevented exercise-induced
corticosterone levels. ***p < 0.0001, **p < 0.01 and *p < 0.05. E) Plasma
corticosterone levels during the final running session were positively associated with
exercise levels.
Figure 4. Exercise levels have limited impact on spatial and recognition memory.
A) Mean + SE change in spontaneous alternation rate (%) after blockade of exercise
induced glucocorticoid receptor (GRs) activation with mifepristone (30 mg/kg i.p.)
and dopamine D2/D3 receptor activation with sulpiride (25 or 50 mg/kg i.p.). B)
Mean + SE preference (%) for the novel object in the test phase of the object
recognition test. While all mice significantly discriminated the novel object (###p <
0.0001, ##p < 0.01 and #p < 0.05 compared to chance levels), mifepristone and the
higher dose of sulpiride (50 mg/kg, i.p.) significantly reduced performance. At the 25
mg/kg dose, blockade of exercised-induced D2/D3 activation also reduced recognition
memory. ***p < 0.0001, **p < 0.01 and *p < 0.05. C) Mean + SE preference (%) for
the object at the novel location. There was no significant effect of either treatment
regardless of exercise. D) Levels of discrimination of spatial location were positively
associated with exercise levels throughout the treatment phase.
Figure 5. Exercise levels are related to emotionality and curiosity. A) Mean + SE
distance moved (metres) in a 30 minutes open-field session. Ambulatory activity is
reduced in mice treated with 25 mg/kg of sulpiride, regardless of exercise. B) Mean +
SE number of faecal pellets in the open-field. C) The number of faecal pellets was
positively associated with exercise levels throughout the treatment phase. D) Mean +
SE time (seconds) spent exploring the objects during the acquisition of the object
recognition test. Blockade of D2/D3 receptors during exercise increased object
investigation, compared to vehicle-treated running mice. E) Exploration times during
the acquisition trial of the object recognition test were negatively associated with
exercise levels throughout the treatment phase. F) Mean + SE time (seconds) spent
exploring the objects during the acquisition of the object location test. Antagonism of
D2/D3 receptors during exercise increased object investigation. **p < 0.01 and *p <
0.05.
Table 1. Results of the ANOVAs performed on each experimental variable.
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Table 1.
* One mifepristone-treated mouse was excluded due to issues with the injection. N/A: non applicable.
Exercise Treatment Time Exercise X
Treatment
Exercise X
Time
Treatment X
Time
Exercise X
Treatment X
Time
Running distances
Sessions (1-20)
Weeks 3-6
N/A
N/A
F(3,60)=10.49
p<0.001
F(3,31)=8.54
p=0.0003
F(20,60)=5.00
p<0.001
F(4,124)=11.56
p<0.001
N/A
N/A
N/A
N/A
F(3,60)=1.85
p=0.0002
F(12,124)=5.61
p<0.001
N/A
N/A
Final session (week 8)* N/A F(3,30)=4.52
p=0.0099
N/A N/A N/A N/A N/A
Corticosterone levels* F(1,57)=25.98
p<0.0001
F(3,57)=3.39
p=0.024
N/A F(3,57)=1.96
p=0.13
N/A N/A N/A
Spontaneous alternation
Alternation rate F(1,59)=0.05
p=0.82
F(3,59)=0.56
p=0.64
F(1,59)=16.78
p<0.001
F(3,59)=0.25
p=0.86
F(1,59)=0.18
p=0.67
F(3,59)=1.36
p=0.26
F(3,59)=0.47
p=0.65
Improvement in alternation
rate
F(1,59)=0.18
p=0.68
F(3,59)=1.36
p=0.26
N/A F(3,59)=0.56
p=0.66
N/A N/A N/A
Open field
Distance moved F(1,59)=3.35
p=0.07
F(3,59)=3.53
p=0.024
N/A F(3,59)=0.12
p=0.95
N/A N/A N/A
% distance in the centre F(1,59)=0.90
p=0.35
F(3,59)=0.66
p=0.58
N/A F(3,59)=0.01
p=0.99
N/A N/A N/A
Number of faecal pellets F(1,59)=0.11
p=0.74
F(3,59)=0.53
p=0.66
N/A F(3,59)=1.21
p=0.31
N/A N/A N/A
Exercise Treatment Trial Exercise X
Treatment
Exercise X
Trial
Treatment X
Trial
Exercise X
Treatment X
Trial
Object recognition
Exploration times F(1,59)=0.05
p=0.82
F(3,59)=10.73
p<0.001
F(1,59)=0.60
p=0.44
F(3,59)=1.97
p=0.13
F(1,59)=0.11
p=0.74
F(3,59)=2.02
p=0.12
F(3,59)=1.09
p=0.36
Recognition index F(1,59)=4.42
p=0.04
F(3,59)=3.13
p=0.032
N/A F(3,59)=1.75
p=0.16
N/A N/A N/A
Object location
Exploration times F(1,59)=20.24
p<0.001
F(3,59)=4.09
p=0.01
F(1,59)=16.78
p<0.001
F(3,59)=0.25
p=0.86
F(1,59)=5.89
p=0.02
F(3,59)=0.69
p=0.56
F(3,59)=0.82
p=0.49
Location index F(1,59)=3.00
p=0.09
F(3,59)=1.78
p=0.16
N/A F(3,59)=0.77
p=0.52
N/A N/A N/A
 Corticosterone synthesis contributes to voluntary wheel running performance
 Effects of corticosterone on motivation to exercise are not mediated by GRs
 Blockade of dopamine D2/D3 receptors dose-dependently reduces running
activity
 Reducing motivation to exercise is not sufficient to alter behaviour in C57BL6
mice
A)
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Supplementary figure 1. Activation of dopaminergic D2/D3 receptors
motivates voluntary wheel running. A) In trained mice, after baseline
assessment of spontaneous alternation performance, the glucocorticoid
receptor (GRs) antagonist mifepristone (30 mg/kg i.p.) and the D2/D3
antagonist (25 or 50 mg/kg i.p.) were administered prior to each running
session to determine the extent to which their activation during exercise
contributes to running performance. Mean + SE distance ran (km) the
last 3 days of training and during each of the 20 running session under
treatment. Antagonism of exercised-induced GR activation attenuates
running performance during the first week of treatment, mostly on the
first and 3rd session while antagonism of D2/D3 receptor activation dose-
dependently reduces running performance. ***p < 0.0001, **p < 0.01
and *p < 0.05 compared to pre-treatment levels. B) Plasma
corticosterone levels during the final running session were positively
associated with exercise levels throughout the treatment phase.
Supplementary Table 1. Mean + SE body weight and performance for all
behavioural variables.
Sedentary Running
Body Weight (grams)
Day 0
Day 49
Weight gain
24.29 + 0.80
26.84 + 0.54
2.55 + 0.42
25.18 + 0.26
26.94 + 0.51
1.76 + 0.37
Spontaneous Alternation Rate (%)
Day 0
Day 38
63.75 + 6.57
75.00 + 6.45
62.50 + 6.18
55.00 + 8.58
Open Field
Distance travelled (metres)
% distanced travelled in the centre
% time spent in the centre
Number of faecal pellets
90.97 + 3.22
11.75 + 0.53
9.31 + 0.84
6.80 + 0.61
96.17 + 4.84
10.84 + 0.38
8.02 + 0.71
5.90 + 0.86
Novel Object Recognition
Exploration Times Trial 1 (seconds)
Exploration Times Trial 2 (seconds)
Recognition Index (%)
52.20 + 4.90
48.65 + 4.54
57.60 + 3.02*
64.00 + 9.32
65.75 + 9.34
62.95 + 2.18**
Novel Object Location
Exploration Times Trial 1 (seconds)
Exploration Times Trial 2 (seconds)
Location Index (%)
51.45 + 5.93
45.75 + 2.86
53.35 + 3.27
54.65 + 8.23
56.45 + 7.66
56.85 + 3.49
*p < 0.5, **p < 0.01 compared to chance 50%
Supplementary Table 2. Behavioural effects of enrichment and injection. Data are
presented as means + SE.
Vehicle -
No wheel
Vehicle -
Sedentary
Vehicle -
Running
Non injected -
Running
Running distances (km)
Training
Week 1
Week 2
Week 3
Week 4
Final Session
0.73 ± 0.05
0.70 ± 0.08
0.78 ± 0.06
0.76 ± 0.08
0.75 ± 0.08
0.76 ± 0.06
0.60 ± 0.02
0.67 ± 0.08
0.78 ± 0.12
0.77 ± 0.10
0.77 ± 0.10
0.65 ± 0.08
Corticosterone levels (ng/ml) 60.24 ± 4.94 63.80 ± 5.66 106.04 ± 7.52 100.01 ± 8.08
Alternation Rate (%)
Before treatment (Day 3)
Day 34
43.75 ± 9.45
60.94 ± 7.26
45.31 ± 7.45
62.50 ± 11.08
45.83 ± 8.84
62.50 ± 6.59
45.31 ± 11.56
60.94 ± 6.44
Open Field
Distance travelled (metres)
% distanced travelled in the centre
% time spent in the centre
Number of faecal pellets
82.06 ± 5.33
13.38 ± 0.97
10.70 ± 1.21
5.00 ± 0.46
82.07 ± 4.20
14.88 ± 0.89
11.96 ± 0.88
4.62 ± 0.70
88.50 ± 4.94
15.54 ± 0.98
12.56 ± 1.40
4.22 ± 0.72
88.72 ± 4.65
15.36 ± 0.72
11.88 ± 0.84
5.62 ± 1.10
Novel Object Recognition
Exploration Times Trial 1 (seconds)
Exploration Times Trial 2 (seconds)
Recognition Index (%)
34.94 + 7.13
42.75 + 6.33
62.21 + 4.17*
73.25 + 5.83a
68.62 + 3.93a
65.54 + 1.99*
59.89 + 9.09
62.67 + 8.59
62.98 + 1.82*
84.25 + 7.30
69.50 + 7.54
59.54 + 3.31*
Novel Object Location
Exploration Times Trial 1 (seconds)
Exploration Times Trial 2 (seconds)
Location Index (%)
39.00 + 7.22
45.56 + 6.26
65.83 + 4.00*
51.75 + 8.23
55.56 + 7.66
55.08 + 4.43
66.89 + 3.92
66.44 + 5.97
57.23 + 3.69
74.75 + 10.05
63.81 + 5.80
59.89 + 3.44*
a, p < 0.01 compared to vehicle-no wheel
*, p < 0.05 compared to chance levels (50%)
Supplementary table 3. Mean + SE body weight and behavioural performance for variables not affected by exercise or treatment.
*, p<0.05 compared to chance levels (50%)
##, p<0.01 compared to vehicle-treated groups
Vehicle Mifepristone Sulpiride 25mg/kg Sulpiride 50mg/kg
Sedentary Running Sedentary Running Sedentary Running Sedentary Running
Body weight
Prior to Training
Day 38
Weight gain
23.50 ± 0.88
25.50 ± 0.64
2.00 ± 0.48
23.45 ± 0.56
26.18 ± 0.23
2.72 ± 0.49
22.65 ± 0.54
24.00 ± 0.45
1.35 ± 0.36
24.49 ± 0.37
24.58 ± 0.45
0.09 ± 0.44
23.62 ± 0.47
26.34 ± 0.52
2.71 ± 0.49
23.04 ± 0.83
26.55 ± 0.29
3.51 ± 0.67
22.91 ± 0.88
25.96 ± 0.81
3.05 ± 0.42
23.82 ± 0.54
26.17 ± 0.59
2.35 ± 0.49
Spontaneous alternation
Day 3 alternation rate (%)
Day 34 alternation rate (%)
45.31 ± 7.45
62.50 ± 11.08
45.83 ± 8.84
62.50 ± 6.59
45.31 ± 10.91
48.43 ± 9.86
47.22 ± 10.16
48.61 ± 7.92
45.31 ± 7.81
59.37 ± 4.57
50.00 ± 8.33
70.83* ± 5.59
45.31 ± 9.13
67.19* ± 6.22
48.44 ± 10.14
54.69 ± 10.28
Anxiety-related behaviour in open-field
% distance in the centre
Number of faecal pellets
14.88 ± 0.89
4.62 ± 0.70
15.54 ± 0.98
4.22 ± 0.72
14.66 ± 0.97
4.87 ± 1.11
15.17 ± 1.07
3.33 ± 0.71
14.60 + 1.12
4.00 ± 0.89
15.40 ± 0.99
5.44 ± 0.87
15.82 ± 0.77
5.12 ± 0.72
16.51 ± 1.04
4.87 ± 0.51
Object exploration times
Object location (recognition trial)
Object location (retention trial)
68.62 ± 3.93
55.56 ± 3.92
62.66 ± 8.59
66.44 ± 5.97
66.62 ± 6.78
49.44 ± 2.07
61.33 ± 6.34
60.44 ± 2.20
72.62 + 4.89
55.06 ± 5.82
80.39 ± 7.70
67.17 ± 6.40
#
84.69 ± 5.48
65.75 ± 4.42
#
89.50 ± 7.08
72.62 ± 5.73
